pharma - Latest News on pharma | Read Breaking News on Zee News
No non-compete clause in case of FDI in pharma deals

No non-compete clause in case of FDI in pharma deals

Last Updated: Monday, April 21, 2014, 22:10

India allows 100 percent FDI in pharma sector.

Ranbaxy's journey as a company to end after merger with Sun

Last Updated: Sunday, April 20, 2014, 12:27

Ranbaxy Laboratories will cease to exist as a company after completion of the USD 4 billion merger with Sun Pharmaceuticals, although its brands will be kept alive in over 100 markets.

Cabinet Secretary calls meet of top officials on India-US pharma issue

Last Updated: Friday, April 18, 2014, 16:59

Cabinet Secretary Ajit Seth has called a meeting of top bureaucrats on Monday to chalk out a strategy to deal with the intellectual property rights (IPR) issues being raised by the US.

GlaxoSmithKline Pharma Q1 Net dips 43% to Rs 96.5 cr

Last Updated: Thursday, April 17, 2014, 17:30

GlaxoSmithKline Pharmaceuticals Thursday posted 42.87 percent decline in its net profit at Rs 96.54 crore for the first quarter ended March 31, 2014, as the company continued to be impacted by the revamped price control order.

Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod

Last Updated: Wednesday, April 16, 2014, 14:46

The company has started selling 1 mg, 2 mg and 3 mg tablets of Eszopiclone.

Sun Pharma chief hopes the worst is over for Ranbaxy

Last Updated: Wednesday, April 09, 2014, 22:12

Sun Pharma would have to do a lot of work to get USFDA to revoke the ban on Ranbaxy facilities but it has not put any time-frame for this, company Chairman Israel Makov said Wednesday.

Sun Pharma denies insider trading charges in Ranbaxy deal

Last Updated: Wednesday, April 09, 2014, 18:33

Sun Pharma Wednesday denied insider trading charges against Silverstreet Developers LLP - its wholly owned arm - in the USD 4 billion acquisition deal of Ranbaxy Laboratories.

Sun Pharma plans gradual phase-out of Ranbaxy drugs in US: Sources

Last Updated: Wednesday, April 09, 2014, 17:52

Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States after completing a USD 3.2 billion takeover of its loss-making rival, sources with direct knowledge of the matter said.

Sun Pharma shares gain 7%, up 2nd day post Ranbaxy deal

Last Updated: Wednesday, April 09, 2014, 17:38

The scrip ended 6.91 percent up at Rs 627.80 on the BSE. During the day, it surged 8 percent to touch Rs 634.80. Ranbaxy stock rose 4.90 percent to Rs 467.

Sun Pharma surges as brokers welcome Ranbaxy purchase

Last Updated: Wednesday, April 09, 2014, 12:49

On Monday, Bank of America Merrill Lynch also upgraded Sun Pharma to "buy" from "neutral", citing a higher price-to-earnings multiple after Ranbaxy`s acquisition.

Ranbaxy: A company at crossroads

Last Updated: Tuesday, April 08, 2014, 12:06

In the biggest deal in two years, Sun Pharmaceutical Industries announced that it will fully acquire rival Ranbaxy Laboratories in an all-stock transaction valued at USD 3.2 billion

Sensex ends 16 pts lower; Sun Pharma gains nearly 3%

Last Updated: Monday, April 07, 2014, 18:54

Sensex Monday closed over 16 points lower with investors turning cautious after the first phase of voting in Lok Sabha elections got under way, amid weakness in global equities.